Clinical Trial Update: SC IL-1Ra in SAH - Phase III Trial (SCIL) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for SC IL-1Ra in subarachnoid hemorrhage is underway, with the status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• SC IL-1Ra

Snippet

Sponsor: University of Manchester | Conditions: Subarachnoid Hemorrhage | Phase 3 | Status: UNKNOWN